pMJ922 Citations (4)

Originally described in: Maximizing mutagenesis with solubilized CRISPR-Cas9 ribonucleoprotein complexes.
Burger A, Lindsay H, Felker A, Hess C, Anders C, Chiavacci E, Zaugg J, Weber LM, Catena R, Jinek M, Robinson MD, Mosimann C Development. 2016 Apr 29. pii: dev.134809. PubMed Journal

---

Articles Citing pMJ922

Articles
A Rapid Method for Directed Gene Knockout for Screening in G0 Zebrafish. Wu RS, Lam II, Clay H, Duong DN, Deo RC, Coughlin SR. Dev Cell. 2018 Jul 2;46(1):112-125.e4. doi: 10.1016/j.devcel.2018.06.003. PubMed
Impact of Formulation Conditions on Lipid Nanoparticle Characteristics and Functional Delivery of CRISPR RNP for Gene Knock-Out and Correction. Walther J, Wilbie D, Tissingh VSJ, Oktem M, van der Veen H, Lou B, Mastrobattista E. Pharmaceutics. 2022 Jan 17;14(1):213. doi: 10.3390/pharmaceutics14010213. PubMed
A Robust Expression and Purification Method for Production of SpCas9-GFP-MBP Fusion Protein for In Vitro Applications. Fleitas AL, Senorale M, Vidal S. Methods Protoc. 2022 May 28;5(3). pii: mps5030044. doi: 10.3390/mps5030044. PubMed
Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 (phox) -deficient chronic granulomatous disease. Siow KM, Gungor M, Wrona D, Raimondi F, Pastukhov O, Tsapogas P, Menzi T, Schmitz M, Kulcsar PI, Schwank G, Schulz A, Jinek M, Modlich U, Siler U, Reichenbach J. Mol Ther Nucleic Acids. 2024 May 24;35(3):102229. doi: 10.1016/j.omtn.2024.102229. eCollection 2024 Sep 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.